PayZen: Over 2 in 5 Patients Pick AI Over Doctor on Cost

What happened

A new report from healthcare payments company PayZen finds that more than two in five patients would opt for an AI tool over an in-person doctor visit when confronted with the cost of traditional care. The finding points to affordability, rather than preference for technology itself, as a key factor shaping how patients choose between digital and human-delivered care.

Why it matters

For healthcare providers and payers, this signals that channel choice is increasingly an economic decision as much as a clinical or experience one. When cost becomes the deciding factor, AI tools risk being adopted by default rather than by design — used because they are cheaper or more accessible, not necessarily because they deliver the best outcome for a given need.

This has direct implications for how health systems design their digital front doors. If price sensitivity is pushing patients toward AI triage, symptom-checkers or virtual assistants, providers need to ensure those tools are clinically sound, clearly scoped, and backed by an easy path to human care when needed — rather than treating AI as a cost-containment shortcut that quietly degrades care quality or trust.

By the numbers

• More than 2 in 5 patients surveyed said they would choose an AI tool over an in-person doctor visit when weighing the cost of traditional care.

The Renascence take

The headline number is really a story about affordability masquerading as a story about technology preference. That distinction matters enormously for how organisations should respond.

Cost-driven channel switching is a classic behavioral-economics signal: patients aren't choosing AI because they trust it more, they're choosing it because the alternative feels financially risky. Treating this as "AI adoption" and declaring victory would be a mistake — the real task is redesigning the cost conversation itself, so patients don't have to choose between their wallet and the standard of care they actually need. Providers that get this right will pair AI access with transparent, friction-free pricing and a visible bridge back to human clinicians; those that don't risk building a two-tier system where affordability, not clinical judgement, quietly decides who gets seen by a doctor at all.